ISSN 2996-8380
Applications of Olaparib and Durvalumab Combination Therapy for a Founder BRCA1 Mutation in the Chinese Han Population: A Literature Review
Applications of Olaparib and Durvalumab Combination Therapy for a Founder BRCA1 Mutation in the Chinese Han Population: A Literature Review
Li, Claire. 2026. “Applications of Olaparib and Durvalumab Combination Therapy for a Founder BRCA1 Mutation in the Chinese Han Population: A Literature Review.” Scholarly Review Journal Fall 2026 (17). https://doi.org/10.70121/001c.169631.